Replies to post #42078 on Biotech Values

[Jonathan Robinson]

Now he introduces legislation for generic biopharma drugs. Looks like he comes down squarely on the side of cheaper drugs regardless of whether it violates intellectual property rights or not.


Any reason biopharma patents should go longer than pharma patents?

Jon